KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Equity Ratio (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Equity Ratio for 17 consecutive years, with 0.61 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 3.95% to 0.61 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.61 through Dec 2025, up 3.95% year-over-year, with the annual reading at 0.61 for FY2025, 3.95% up from the prior year.
  • Equity Ratio hit 0.61 in Q4 2025 for Abbott Laboratories, up from 0.61 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.61 in Q4 2025 to a low of 2.79 in Q4 2022.
  • Historically, Equity Ratio has averaged 0.03 across 5 years, with a median of 0.0 in 2021.
  • Biggest five-year swings in Equity Ratio: crashed 9784.71% in 2022 and later soared 1710.72% in 2024.
  • Year by year, Equity Ratio stood at 0.03 in 2021, then plummeted by 9784.71% to 2.79 in 2022, then skyrocketed by 96.17% to 0.11 in 2023, then surged by 646.8% to 0.59 in 2024, then increased by 3.95% to 0.61 in 2025.
  • Business Quant data shows Equity Ratio for ABT at 0.61 in Q4 2025, 0.61 in Q3 2025, and 0.08 in Q2 2025.